Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gentium tumbles 29% on drug setback, downgrade
Gentium tumbles 29% on drug setback, downgrade
Gentium tumbles 29% on drug setback, downgrade
Submitted by
admin
on August 18, 2011 - 5:44pm
Source:
Marketwatch
News Tags:
Gentium
Defibrotide
Headline:
Gentium tumbles 29% on drug setback, downgrade
Do Not Allow Advertisers to Use My Personal information
